These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 15993596)

  • 1. Bradykinin B1 antagonists: SAR studies in the 2,3-diaminopyridine series.
    Kuduk SD; Chang RK; Ng C; Murphy KL; Ransom RW; Tang C; Prueksaritanont T; Freidinger RM; Pettibone DJ; Bock MG
    Bioorg Med Chem Lett; 2005 Sep; 15(17):3925-9. PubMed ID: 15993596
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 2,3-diaminopyridine bradykinin B1 receptor antagonists.
    Kuduk SD; Ng C; Feng DM; Wai JM; Chang RS; Harrell CM; Murphy KL; Ransom RW; Reiss D; Ivarsson M; Mason G; Boyce S; Tang C; Prueksaritanont T; Freidinger RM; Pettibone DJ; Bock MG
    J Med Chem; 2004 Dec; 47(26):6439-42. PubMed ID: 15588075
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bradykinin B1 antagonists: biphenyl SAR studies in the cyclopropanecarboxamide series.
    Kuduk SD; DiPardo RM; Chang RK; Di Marco CN; Murphy KL; Ransom RW; Reiss DR; Tang C; Prueksaritanont T; Pettibone DJ; Bock MG
    Bioorg Med Chem Lett; 2007 Jul; 17(13):3608-12. PubMed ID: 17482459
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 2,3-Diaminopyridine as a platform for designing structurally unique nonpeptide bradykinin B1 receptor antagonists.
    Feng DM; Wai JM; Kuduk SD; Ng C; Murphy KL; Ransom RW; Reiss D; Chang RS; Harrell CM; MacNeil T; Tang C; Prueksaritanont T; Freidinger RM; Pettibone DJ; Bock MG
    Bioorg Med Chem Lett; 2005 May; 15(9):2385-8. PubMed ID: 15837330
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bioactivation of 2,3-diaminopyridine-containing bradykinin B1 receptor antagonists: irreversible binding to liver microsomal proteins and formation of glutathione conjugates.
    Tang C; Subramanian R; Kuo Y; Krymgold S; Lu P; Kuduk SD; Ng C; Feng DM; Elmore C; Soli E; Ho J; Bock MG; Baillie TA; Prueksaritanont T
    Chem Res Toxicol; 2005 Jun; 18(6):934-45. PubMed ID: 15962928
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cyclopropylamino acid amide as a pharmacophoric replacement for 2,3-diaminopyridine. Application to the design of novel bradykinin B1 receptor antagonists.
    Wood MR; Schirripa KM; Kim JJ; Wan BL; Murphy KL; Ransom RW; Chang RS; Tang C; Prueksaritanont T; Detwiler TJ; Hettrick LA; Landis ER; Leonard YM; Krueger JA; Lewis SD; Pettibone DJ; Freidinger RM; Bock MG
    J Med Chem; 2006 Feb; 49(4):1231-4. PubMed ID: 16480259
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discovery of dihydroquinoxalinone acetamides containing bicyclic amines as potent Bradykinin B1 receptor antagonists.
    Chen JJ; Qian W; Biswas K; Viswanadhan VN; Askew BC; Hitchcock S; Hungate RW; Arik L; Johnson E
    Bioorg Med Chem Lett; 2008 Aug; 18(16):4477-81. PubMed ID: 18674903
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Indazole derivatives as novel bradykinin B1 receptor antagonists.
    Bodmer-Narkevitch V; Anthony NJ; Cofre V; Jolly SM; Murphy KL; Ransom RW; Reiss DR; Tang C; Prueksaritanont T; Pettibone DJ; Bock MG; Kuduk SD
    Bioorg Med Chem Lett; 2010 Dec; 20(23):7011-4. PubMed ID: 20971001
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bradykinin B1 receptor antagonists: an alpha-hydroxy amide with an improved metabolism profile.
    Kuduk SD; Chang RK; Dipardo RM; Di Marco CN; Murphy KL; Ransom RW; Reiss DR; Tang C; Prueksaritanont T; Pettibone DJ; Bock MG
    Bioorg Med Chem Lett; 2008 Sep; 18(18):5107-10. PubMed ID: 18722115
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discovery of potent, orally bioavailable phthalazinone bradykinin B1 receptor antagonists.
    Biswas K; Peterkin TA; Bryan MC; Arik L; Lehto SG; Sun H; Hsieh FY; Xu C; Fremeau RT; Allen JR
    J Med Chem; 2011 Oct; 54(20):7232-46. PubMed ID: 21902230
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alpha-hydroxy amides as a novel class of bradykinin B1 selective antagonists.
    Wood MR; Schirripa KM; Kim JJ; Kuduk SD; Chang RK; Di Marco CN; DiPardo RM; Wan BL; Murphy KL; Ransom RW; Chang RS; Holahan MA; Cook JJ; Lemaire W; Mosser SD; Bednar RA; Tang C; Prueksaritanont T; Wallace AA; Mei Q; Yu J; Bohn DL; Clayton FC; Adarayn ED; Sitko GR; Leonard YM; Freidinger RM; Pettibone DJ; Bock MG
    Bioorg Med Chem Lett; 2008 Jan; 18(2):716-20. PubMed ID: 18061443
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dual antagonists of the bradykinin B1 and B2 receptors based on a postulated common pharmacophore from existing non-peptide antagonists.
    Morissette G; Bouthillier J; Marceau F
    Biol Chem; 2006 Feb; 387(2):189-94. PubMed ID: 16497151
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potent bradykinin B1 receptor antagonists: 4-substituted phenyl cyclohexanes.
    Su DS; Lim JL; Markowitz MK; Wan BL; Murphy KL; Reiss DR; Harrell CM; O'Malley SS; Ransom RW; Chang RS; Pettibone DJ; Tang C; Prueksaritanont T; Freidinger RM; Bock MG
    Bioorg Med Chem Lett; 2007 Jun; 17(11):3006-9. PubMed ID: 17428657
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aryl sulfonamides containing tetralin allylic amines as potent and selective bradykinin B1 receptor antagonists.
    Liu Q; Qian W; Li A; Biswas K; Chen JJ; Fotsch C; Han N; Yuan C; Arik L; Biddlecome G; Johnson E; Kumar G; Lester-Zeiner D; Ng GY; Hungate RW; Askew BC
    Bioorg Med Chem Lett; 2010 Aug; 20(15):4593-7. PubMed ID: 20573508
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aryl sulfones as novel bradykinin B1 receptor antagonists for treatment of chronic pain.
    Biswas K; Aya T; Qian W; Peterkin TA; Chen JJ; Human J; Hungate RW; Kumar G; Arik L; Lester-Zeiner D; Biddlecome G; Manning BH; Sun H; Dong H; Huang M; Loeloff R; Johnson EJ; Askew BC
    Bioorg Med Chem Lett; 2008 Sep; 18(17):4764-9. PubMed ID: 18706809
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 1-Benzylbenzimidazoles: the discovery of a novel series of bradykinin B(1) receptor antagonists.
    Guo Q; Chandrasekhar J; Ihle D; Wustrow DJ; Chenard BL; Krause JE; Hutchison A; Alderman D; Cheng C; Cortright D; Broom D; Kershaw MT; Simmermacher-Mayer J; Peng Y; Hodgetts KJ
    Bioorg Med Chem Lett; 2008 Sep; 18(18):5027-31. PubMed ID: 18752949
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Discovery of dehydro-oxopiperazine acetamides as novel bradykinin B1 receptor antagonists with enhanced in vitro potency.
    Qian W; Chen JJ; Human J; Aya T; Zhu J; Biswas K; Peterkin T; Hungate RW; Arik L; Johnson E; Kumar G; Joseph S; Jona J; Guo HX; Wu Z
    Bioorg Med Chem Lett; 2012 Jan; 22(2):1061-7. PubMed ID: 22197141
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A new class of bradykinin 1 receptor antagonists containing the piperidine acetic acid tetralin core.
    Fotsch C; Biddlecome G; Biswas K; Chen JJ; D'Amico DC; Groneberg RD; Han NB; Hsieh FY; Kamassah A; Kumar G; Lester-Zeiner D; Liu Q; Mareska DA; Riahi BB; Wang YJ; Yang K; Zhan J; Zhu J; Johnson E; Ng G; Askew BC
    Bioorg Med Chem Lett; 2006 Apr; 16(8):2071-5. PubMed ID: 16464576
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 5-Piperazinyl pyridine carboxamide bradykinin B1 antagonists.
    Kuduk SD; Di Marco CN; Chang RK; Wood MR; Kim JJ; Schirripa KM; Murphy KL; Ransom RW; Tang C; Torrent M; Ha S; Prueksaritanont T; Pettibone DJ; Bock MG
    Bioorg Med Chem Lett; 2006 May; 16(10):2791-5. PubMed ID: 16529929
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sulfonamido-aryl ethers as bradykinin B1 receptor antagonists.
    Cole AG; Metzger A; Brescia MR; Qin LY; Appell KC; Brain CT; Hallett A; Ganju P; Denholm AA; Wareing JR; Ritchie TJ; Drake GM; Bevan SJ; MacGloinn A; McBryde A; Patel V; Oakley PJ; Nunez X; Gstach H; Schneider P; Baldwin JJ; Dolle RE; McDonald E; Henderson I
    Bioorg Med Chem Lett; 2009 Jan; 19(1):119-22. PubMed ID: 19014884
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.